{"entity":{"id":"nct05552755","kind":"trial","name":"Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)","aka":[],"tldr":"A phase 1/2 trial of REC-4881 run by Recursion Pharmaceuticals Inc., now recruiting.","summary":"Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP) is a phase 1/2 interventional study registered as NCT05552755 by Recursion Pharmaceuticals Inc., with 67 participants planned, started 2023-07-10. Conditions recorded: Familial Adenomatous Polyposis. Interventions recorded: REC-4881 and Placebo.","status":"recruiting","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT05552755","url":"https://clinicaltrials.gov/study/NCT05552755"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["fap-associated-colorectal-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["rec-4881"],"companies":["recursion"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05552755","phase":"1/2","setting":"A Phase 1b-2, Multicenter, Trial to Evaluate the Efficacy, Safety, Pharmacokintetics, and Pharmacodynamics of REC-4881 in Patients With Familial Adenomatous Polyposis (FAP)","sponsor":"Recursion Pharmaceuticals Inc.","enrolled":67,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05552755/","neighbours":{"cancer":[{"id":"fap-associated-colorectal-cancer","kind":"cancer","name":"Familial adenomatous polyposis-associated colorectal cancer","route":"/cancers/fap-associated-colorectal-cancer/"}],"drug":[{"id":"rec-4881","kind":"drug","name":"REC-4881","route":"/drugs/rec-4881/"}],"company":[{"id":"recursion","kind":"company","name":"Recursion Pharmaceuticals","route":"/companies/recursion/"}]}}